She Didn't Have Osteoporosis. She Had Bad Aim.

What a forty-year-old X-ray reveals about the bone health conversation most doctors still aren't having.

About forty years ago, an elderly woman was wheeled into a small New Hampshire emergency room from a nursing home. She had stood up from her bed and fractured both hips simultaneously.

The X-ray told the expected story at first. Her bones were so demineralized the femurs were barely visible on the film. But alongside each nearly invisible femur — about a quarter of an inch to the outside — were two bright white crystalline pipes. Vivid and unmistakable.

Her calcified femoral arteries.

The physician looking at that film — a young Dr. Tom Cowan, who has told this story many times in the years since — said something that contains the seed of everything mainstream osteoporosis medicine still tends to miss:

She doesn't have osteoporosis. She has bad aim.

This woman did not lack calcium. Her body had plenty of the minerals that should have gone into bone. It had simply deposited them in the wrong place. A quarter inch away from where they were supposed to go.

What Bone Actually Is

To understand why that matters, you have to understand what bone is made of — because most of the osteoporosis conversation talks about it as though it's just a mineral deposit, when it isn't.

Bone has two components. The mineral part — primarily calcium and phosphate — gives bone its hardness and compression strength. But the organic part — primarily collagen — gives bone its tensile strength, its flexibility, and its ability to absorb impact without snapping.

A healthy bone bends slightly under load. It doesn't break because the collagen matrix is intact and supple enough to distribute stress across the structure. This is why babies, whose bone mineral density is quite low, almost never fracture. Their collagen matrix is excellent. The bone bends; it doesn't break.

Two women with identical DEXA scores can have very different fracture risk — because the scan counts the mineral and says nothing about the framework it sits on.

This is one reason bone health connects directly to homocysteine: elevated homocysteine can interfere with collagen cross-linking, which helps explain why fracture risk is not always captured by DEXA alone.

An older person whose bone snaps under her own body weight doesn't necessarily lack mineral. She may lack the protein scaffolding onto which mineral is deposited — and increasingly, the research is showing that this is the part of the conversation that's been missing.

Emerging research is also examining how chronic inflammation contributes to bone loss, which is one reason compounds like quercetin have attracted growing interest among researchers studying healthy aging.

Multiple peer-reviewed studies have now confirmed that bone mineral density alone does not reliably predict fracture risk. Research published in the Journal of Bone and Mineral Research found that fracture resistance depends not only on mineral content but on the quality of the collagen matrix. A study in JBMR Plus put it plainly: there is no indication that increased bone mineral density results in a corresponding decrease in fracture risk. And current data suggests that DXA-based measurements fail to explain nearly 50% of fractures in aging and osteoporotic populations.

The Tool We're Using

The DEXA scan measures one variable: how much mineral is packed into a cross-section of bone. It does this reasonably well. What it cannot assess — by its own technical limitations, confirmed in the medical literature — is the condition of the collagen matrix that gives bone its structural integrity.

This is not a fringe critique. Research scientists working on next-generation diagnostic tools have said exactly this. The standard DXA is insensitive to changes in bone collagen and bone microstructure. Studies have found that 25% of people with normal bone density still carry meaningful fracture risk — people who would be told by their scan that everything is fine.

None of this means the DEXA scan has no value. It has value. But it is measuring one dimension of a multi-dimensional structure, and the conversation patients typically have after a low T-score has not kept pace with what the research actually shows.

The Drug Question

Most people who receive an osteoporosis or osteopenia diagnosis are offered a bisphosphonate — Fosamax, Boniva, Actonel, Reclast. These drugs work by suppressing the osteoclasts that break down old bone, which increases measured bone density and reduces certain fracture types, particularly vertebral fractures, in the first few years of use.

What patients are less often told is what happens to bone structure over longer periods of use.

Bone is a living tissue. It constantly remodels — old bone is broken down, new bone is laid down. This turnover serves a purpose: it replaces bone that has accumulated microfractures and microdamage. When you suppress the breakdown side of that process, the density numbers improve, but the underlying tissue ages without being replaced.

Research from Cornell University found that prolonged bisphosphonate use alters bone composition, making it more brittle over time. The mechanism, as described in peer-reviewed literature: suppressed bone turnover leads to accumulation of microfractures and progressive weakening of the tissue. The New England Journal of Medicine published data showing that atypical femur fracture risk — a transverse fracture that bisphosphonates can cause — increases with duration of use, rising from roughly 9 times baseline risk at 3-5 years to over 43 times baseline risk at 8 or more years.

The Cleveland Clinic Journal of Medicine described this as a genuine clinical dilemma: the drugs reduce one type of fracture while, with long-term use, increasing risk of another.

None of this is hidden. It's in the mainstream medical literature. It just doesn't often make it into the ten-minute appointment after the DEXA result comes back.

What Actually Supports Bone

The collagen matrix isn't passive — it's built and maintained by the body when it has what it needs. Several things support it well, and they're worth knowing.

Vitamin K2 plays a specific role in directing calcium into bone rather than into arterial walls — exactly the problem illustrated in that X-ray from forty years ago. K2 activates a protein called osteocalcin, which binds calcium to the bone matrix. Without adequate K2, calcium circulates and tends to deposit where you don't want it. K1, found in leafy greens, and K2 are not the same thing, and most people are deficient in K2 specifically.

Vitamin D3 works alongside K2. D3 increases calcium absorption; K2 directs where it goes. These two are often discussed separately, but they work together. Taking D3 without K2 may increase circulating calcium without ensuring it reaches bone.

Bone health is also closely connected to thyroid function. Even mild thyroid dysfunction can influence bone turnover, which is one reason understanding iodine and thyroid health matters beyond energy and metabolism alone.

Collagen— particularly hydrolyzed collagen peptides — provides the amino acids glycine, proline, and hydroxyproline that the body uses to build and repair the bone matrix. As we age, collagen synthesis slows — one reason healthy aging has to include more than lab numbers. Supplemental collagen, in the right form and dose, has shown meaningful effects on bone quality markers in clinical research.

Magnesium is required for bone formation and for the activation of vitamin D. Many people are deficient, and most of the conversation about bone health focuses on calcium while magnesium gets little attention.

Movement— specifically weight-bearing exercise and resistance training — signals the body to maintain and build bone density. This is one of the most well-established interventions for bone health at any age.

What's notable about this list is that it's not a list of exotic interventions. It's a list of foundational inputs the body needs to do what it was designed to do. When those are in place, the body's own systems for building and maintaining bone work the way they're supposed to work.

QUESTIONS WE HEAR MOST OFTEN

Is low bone density the same thing as high fracture risk?

Not necessarily, and this is one of the most important things to understand. Bone mineral density — what the DEXA scan measures — is one factor in fracture risk, but not the only one. Research shows that the quality of the collagen matrix inside bone is equally important. Two people with identical DEXA scores can have very different fracture risk depending on the health of their bone's protein framework. Density tells part of the story, not the whole story.

Why is calcium going to my arteries instead of my bones?

This is often a vitamin K2 deficiency problem. K2 activates a protein called osteocalcin that directs calcium into bone tissue. Without adequate K2, calcium circulates in the bloodstream and tends to deposit in soft tissues and arterial walls instead. Most people get sufficient K1 from leafy greens, but K2 — found primarily in fermented foods and grass-fed animal products — is a different compound, and deficiency is common.

Are bisphosphonates like Fosamax safe for long-term use?

This is a question worth having an honest conversation with your doctor about. Bisphosphonates are effective at reducing certain fracture types, particularly vertebral fractures, in the first few years of use. What is less often discussed is that long-term use suppresses bone remodeling — the natural process that replaces old, microdamaged bone with new tissue. Research published in the New England Journal of Medicine found that atypical femur fracture risk increases significantly with duration of use. These drugs have a role, but the risks of long-term use deserve more attention than they typically receive.

What actually builds bone collagen?

Bone collagen is built from amino acids — primarily glycine, proline, and hydroxyproline — that the body either produces or takes in through food and supplementation. Hydrolyzed collagen peptides provide these amino acids directly and have shown meaningful effects on bone quality markers in clinical research. Vitamin C is required for collagen synthesis. Magnesium is required for bone formation and for activating vitamin D. Weight-bearing exercise and resistance training signal the body to build and maintain both the mineral and matrix components of bone.

Does a normal DEXA scan mean my bones are healthy?

A normal DEXA result is generally good news, but it isn't a complete picture of bone health. Studies have found that roughly 25% of people with normal bone density still carry meaningful fracture risk — largely because the scan measures mineral content but says nothing about the condition of the collagen matrix that gives bone its flexibility and toughness. If you have other risk factors — a history of falls, low K2 or magnesium intake, long-term corticosteroid use — those are worth discussing alongside the scan result.

The Question Worth Asking

The woman in that emergency room forty years ago had calcium. She had plenty of it. What she didn't have was the right conditions for her body to put it where it belonged.

That's the question worth starting with — not "how do we increase the number on the scan," but "what does this body need to do what it was designed to do?"

It's a different question. And it tends to lead somewhere more useful.

Paul and Ann Malkmus write at AMPMforHealth.com — a faith-informed, food-first resource for people who are already committed to their health and want to go deeper. Educational content. Not medical advice. Always consult your healthcare provider before making changes to your health practice.